ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 125 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $584,000 | +62.2% | 30,949 | +1.3% | 0.00% | +50.0% |
| Q2 2019 | $360,000 | -21.2% | 30,564 | -8.6% | 0.00% | -33.3% |
| Q1 2019 | $457,000 | +52.3% | 33,445 | +14.1% | 0.00% | +50.0% |
| Q4 2018 | $300,000 | -48.5% | 29,302 | -16.2% | 0.00% | -50.0% |
| Q3 2018 | $582,000 | +1.7% | 34,954 | -3.4% | 0.00% | 0.0% |
| Q2 2018 | $572,000 | +14.2% | 36,187 | -8.3% | 0.00% | +33.3% |
| Q1 2018 | $501,000 | -4.8% | 39,470 | -14.0% | 0.00% | -25.0% |
| Q4 2017 | $526,000 | +1.0% | 45,916 | +8.0% | 0.00% | -20.0% |
| Q3 2017 | $521,000 | +51.5% | 42,497 | +41.4% | 0.01% | +66.7% |
| Q2 2017 | $344,000 | -48.8% | 30,045 | -7.0% | 0.00% | -57.1% |
| Q1 2017 | $672,000 | -20.8% | 32,296 | -20.8% | 0.01% | -22.2% |
| Q4 2016 | $848,000 | -30.0% | 40,753 | +10.3% | 0.01% | -47.1% |
| Q3 2016 | $1,211,000 | +13.0% | 36,948 | -13.9% | 0.02% | +21.4% |
| Q2 2016 | $1,072,000 | +24.2% | 42,926 | +21.8% | 0.01% | +16.7% |
| Q1 2016 | $863,000 | -32.1% | 35,251 | -8.4% | 0.01% | -20.0% |
| Q4 2015 | $1,271,000 | +9.6% | 38,476 | +8.6% | 0.02% | -6.2% |
| Q3 2015 | $1,160,000 | -33.5% | 35,418 | +7.6% | 0.02% | -33.3% |
| Q2 2015 | $1,744,000 | +86.1% | 32,925 | +1.4% | 0.02% | +118.2% |
| Q1 2015 | $937,000 | +45.7% | 32,482 | +46.8% | 0.01% | +57.1% |
| Q4 2014 | $643,000 | – | 22,121 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
| Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
| DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
| Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
| Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
| Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
| Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
| BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
| Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |